๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients

โœ Scribed by Lymphoma Study Division of the Korean Cancer Study Group; Y. H. Park; J. J. Lee; M. H. Ryu; S. Y. Kim; D. H. Kim; Y. R. Do; K. H. Lee; S. J. Oh; Y. K. Kim; C. W. Suh; D. S. Heo; B. Y. RYoo; J. K. Kim; H. S. Song; W. S. Lee; H. J. Kim; Y. J. Bang; S. H. Yang; S. K. Sohn; Y. K. Kang

Book ID
105988614
Publisher
Springer
Year
2006
Tongue
English
Weight
188 KB
Volume
85
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Introduction of rituximab in front-line
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients
โœ Stefano Sacchi; Samantha Pozzi; Luigi Marcheselli; Alessia Bari; Stefano Luminar ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 130 KB

## Abstract ## BACKGROUND. It is unclear whether new treatment modalities have improved the survival of follicular lymphoma patients. Some data show that there has been no improvement in survival in the last 3 decades of the 20th century, whereas the results of recent retrospective studies suggest

Multimodality therapeutic outcomes In an
Multimodality therapeutic outcomes In anaplastic thyroid carcinoma: Improved survival in subgroups of patients with localized primary tumors
โœ Ken-ichi Ito; Toru Hanamura; Koichi Murayama; Toshihiro Okada; Takayuki Watanabe ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 281 KB

## Abstract ## Background The aim of the present study was to investigate the role of a multimodality treatment for anaplastic thyroid carcinoma (ATC). ## Methods Clinical data of 40 consecutive patients treated between 1985 and 2009 were retrospectively analyzed. ## Results The median surviva